ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2705

AAA-Atpase p97-HDAC6 Controlled Poly-Ubiquitin Turnover Regulates Apoptotic and Autophagy-Associated Cell Death in Arthritis

Masaru Kato1, Kerstin Klein2, Caroline Ospelt2, Christoph Kolling3, Michihito Kono1, Shinsuke Yasuda1, Renate E. Gay4, Steffen Gay5 and Tatsuya Atsumi1, 1Division of Rheumatology, Endocrinology and Nephrology, Hokkaido University Graduate School of Medicine, Sapporo, Japan, 2Center of Experimental Rheumatology, University Hospital Zurich, Zurich, Switzerland, 3Schulthess Clinic, Zurich, Switzerland, 4Center of Experimental Rheumatology, University Hospital Zurich, Switzerland, Zurich, Switzerland, 5Center of Experimental Rheumatology, University Hospital Zurich, University Zurich, Zurich, Switzerland

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: animal models and rheumatoid arthritis, Apoptosis, autophagy, ER Stress, rheumatoid arthritis, synovium

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, November 10, 2015

Title: Rheumatoid Arthritis - Human Etiology and Pathogenesis Poster III

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: The AAA-ATPase valosin containing protein (p97) and histone deacetylase 6 (HDAC6) interact with each other and are implicated in the degradation of ubiquitin-labelled proteins. We recently described a resistance to apoptotic cell death induced by proteasome inhibition and a hypersensitivity to autophagy-associated cell death under conditions of severe endoplasmic reticulum (ER) stress in rheumatoid arthritis synovial fibroblasts (RASF) compared to osteoarthritis synovial fibroblasts (OASF). The objective of this study was to investigate the role of p97-HDAC6 controlled poly-ubiquitin turnover in apoptotic and autophagy-associated cell death in RASF and in an in vivo arthritis model.

Methods: p97, HDAC6 and poly-ubiquitinated proteins were evaluated by immunohistochemistry, Real-time PCR, immunoblotting and proximal ligation assay. RASF were transfected with siRNA targeting p97 or HDAC6 or treated with the selective p97 inhibitor DBeQ (5 μM). To induce cell death, RASF were treated with TRAIL (100 ng/ml) for 24 hours or the ER stress inducer thapsigargin (TG, 5 nM-5 μM) for 72 hours. 3-methyladenine (5 mM) was used as an autophagy inhibitor. Cell death was evaluated by flow cytometry using annexin V/ propidium iodide staining and a caspase-3 activity assay. Collagen-induced arthritis (CIA) was induced in Lewis rats. Scrambled or p97 siRNA-atelocollagen complexes were injected into ankle joints of rats. CIA was scored according to paw thickness and ankle diameter. Bone erosion was assessed by micro-CT. Proliferation of fibroblasts in rat synovial tissue was quantified by immunolabeling for Hsp47.

Results: The expression of p97 and the expression of HDAC6 were restricted to the lining layer of synovial tissues and were similarly detected in RA and OA patients. The expression of p97 in RASF and OASF was positively related with the expression of HDAC6 at both mRNA (R2 = 0.77, n = 31) and protein (R2 = 0.77, n = 14) level. Interactions of p97-ubiquitin, HDAC6-ubiquitin and p97-HDAC6 were detected in RASF. The siRNA-mediated knockdown of p97 in RASF decreased the expression of HDAC6 but not vice versa. Knockdown of p97 in RASF increased cell death induced by TRAIL (p = 0.009, n = 6), accompanied by caspase-3 activation. Both knockdown and inhibition of p97 in RASF boosted cell death induced by 5 μM TG, accompanied by a massive cytoplasmic vacuolization and the formation of poly-ubiquitinated protein aggregates, and cell death was inhibited by 3-methyladenine. Smaller amounts of TG (50 or 500 nM) induced a cytoplasmic vacuolization and the formation of poly-ubiquitinated protein aggregates in p97–inhibited RASF but not in control RASF. Intra-articular injection of p97 siRNA significantly suppressed CIA (p = 0.002, n = 6), bone erosion (p = 0.02), cartilage destruction (p = 0.03) and proliferation of synovial fibroblasts (p = 0.004) in rats.

Conclusion: Our data indicate that the inhibition of the ATPase p97 promotes both apoptotic and autophagy-associated cell death in RASF and suppresses CIA and proliferation of synovial fibroblasts in vivo. The p97-HDAC6 controlled poly-ubiquitin turnover may be a new potential target in the treatment of arthritis.


Disclosure: M. Kato, None; K. Klein, None; C. Ospelt, None; C. Kolling, None; M. Kono, None; S. Yasuda, None; R. E. Gay, None; S. Gay, None; T. Atsumi, None.

To cite this abstract in AMA style:

Kato M, Klein K, Ospelt C, Kolling C, Kono M, Yasuda S, Gay RE, Gay S, Atsumi T. AAA-Atpase p97-HDAC6 Controlled Poly-Ubiquitin Turnover Regulates Apoptotic and Autophagy-Associated Cell Death in Arthritis [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/aaa-atpase-p97-hdac6-controlled-poly-ubiquitin-turnover-regulates-apoptotic-and-autophagy-associated-cell-death-in-arthritis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/aaa-atpase-p97-hdac6-controlled-poly-ubiquitin-turnover-regulates-apoptotic-and-autophagy-associated-cell-death-in-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology